LAURA LAURENZANO: Open Payments
NPI 1912724758 · SPRING HILL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $395 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $183 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Madrigal Pharmaceuticals | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: RINVOQ, REZDIFFRA, XIFAXAN, ZENPEP, DUPIXENT, VOWST, SKYRIZI, DYSPORT.
Industry payments across TN — which companies pay providers there.
